ArticleOPEN ACCESS

Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma

Bone Marrow Transplantation
DOI: 10.1038/s41409-019-0454-z
17Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Abuelgasim, K. A., Alzahrani, M., Alsharhan, Y., Khairi, M., Hommady, M., Gmati, G., … Damlaj, M. (2019, July 1). Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma. Bone Marrow Transplantation. Nature Publishing Group. https://doi.org/10.1038/s41409-019-0454-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free